JP2023531679A5 - - Google Patents
Info
- Publication number
- JP2023531679A5 JP2023531679A5 JP2022578970A JP2022578970A JP2023531679A5 JP 2023531679 A5 JP2023531679 A5 JP 2023531679A5 JP 2022578970 A JP2022578970 A JP 2022578970A JP 2022578970 A JP2022578970 A JP 2022578970A JP 2023531679 A5 JP2023531679 A5 JP 2023531679A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- patient
- composition according
- inhibitor
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042390P | 2020-06-22 | 2020-06-22 | |
| US63/042,390 | 2020-06-22 | ||
| PCT/US2021/038445 WO2021262695A1 (en) | 2020-06-22 | 2021-06-22 | Methods and compositions for treating hemophilia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531679A JP2023531679A (ja) | 2023-07-25 |
| JP2023531679A5 true JP2023531679A5 (https=) | 2024-07-02 |
Family
ID=76943130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022578970A Pending JP2023531679A (ja) | 2020-06-22 | 2021-06-22 | 血友病を処置するための方法および組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20210393669A1 (https=) |
| EP (1) | EP4168018A1 (https=) |
| JP (1) | JP2023531679A (https=) |
| KR (1) | KR20230027277A (https=) |
| CN (1) | CN115942940A (https=) |
| AU (1) | AU2021296786A1 (https=) |
| BR (1) | BR112022026265A2 (https=) |
| CA (1) | CA3188137A1 (https=) |
| IL (1) | IL299295A (https=) |
| MX (1) | MX2023000164A (https=) |
| TW (1) | TW202216172A (https=) |
| WO (1) | WO2021262695A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240075001A1 (en) * | 2022-05-24 | 2024-03-07 | Darren Rubin | Methods to reduce hemorrhage and mortality on the battlefield and applications for trauma patients |
| US20240000744A1 (en) * | 2022-06-08 | 2024-01-04 | Genzyme Corporation | Treatment of Hemophilia with Fitusiran |
| CN118460655B (zh) * | 2024-07-10 | 2025-01-28 | 凯莱英医药集团（天津）股份有限公司 | 抑制FXI基因表达的siRNA的制备方法 |
| WO2026012399A1 (zh) * | 2024-07-10 | 2026-01-15 | 正大天晴药业集团股份有限公司 | 靶向serpinc1的双链核糖核酸 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9127274B2 (en) | 2012-04-26 | 2015-09-08 | Alnylam Pharmaceuticals, Inc. | Serpinc1 iRNA compositions and methods of use thereof |
| KR20180095843A (ko) | 2015-12-07 | 2018-08-28 | 젠자임 코포레이션 | Serpinc1-연관 장애의 치료를 위한 방법 및 조성물 |
| TW202434265A (zh) * | 2017-07-10 | 2024-09-01 | 美商健贊公司 | 於患有血友病之個體中治療出血事件之方法及組成物 |
-
2021
- 2021-06-22 CA CA3188137A patent/CA3188137A1/en active Pending
- 2021-06-22 JP JP2022578970A patent/JP2023531679A/ja active Pending
- 2021-06-22 MX MX2023000164A patent/MX2023000164A/es unknown
- 2021-06-22 WO PCT/US2021/038445 patent/WO2021262695A1/en not_active Ceased
- 2021-06-22 AU AU2021296786A patent/AU2021296786A1/en active Pending
- 2021-06-22 US US17/354,818 patent/US20210393669A1/en not_active Abandoned
- 2021-06-22 CN CN202180044790.1A patent/CN115942940A/zh active Pending
- 2021-06-22 TW TW110122791A patent/TW202216172A/zh unknown
- 2021-06-22 EP EP21742607.1A patent/EP4168018A1/en active Pending
- 2021-06-22 BR BR112022026265A patent/BR112022026265A2/pt unknown
- 2021-06-22 KR KR1020237002631A patent/KR20230027277A/ko active Pending
-
2022
- 2022-12-20 IL IL299295A patent/IL299295A/en unknown
-
2025
- 2025-09-17 US US19/331,354 patent/US20260014188A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531679A5 (https=) | ||
| Lai et al. | Recombinant interferon-α in inoperable hepatocellular carcinoma: a randomized controlled trial | |
| JP2018138578A5 (https=) | ||
| Goldsmith et al. | Nuclear imaging and clinical features of childhood reflex neurovascular dystrophy: comparison with adults | |
| BR112013010829B1 (pt) | Omposição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| JP2022535127A5 (https=) | ||
| JP2018531605A5 (https=) | ||
| Weary et al. | Chronic urticaria in association with dermatophytosis: response to the administration of griseofulvin | |
| Kasper et al. | Comprehensive management of haemophilia | |
| JP2025500412A5 (https=) | ||
| JP2023544249A5 (https=) | ||
| JP2023020885A5 (https=) | ||
| WO2025195268A1 (zh) | 药物组合物在治疗糖尿病周围神经病变上的应用 | |
| ES3039536T3 (en) | Low dose regimen and formulation of a 5-methyl-1,2,4-oxadiazol-3-yl compound | |
| Kasgari et al. | Combination therapy with remdisivir and tocilizumab for covid-19: Lessons for futures studies | |
| RU2024120372A (ru) | Фитусиран для применения в улучшении сообщаемого пациентом исхода у пациентов с гемофилией | |
| Qi et al. | Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope | |
| RU2053765C1 (ru) | Лекарственное средство для профилактики простудных заболеваний у детей | |
| Chitsaz et al. | Comparison of serum oxytetracycline concentration after intravenous and intraosseous administration in dogs | |
| Bell et al. | Neostigmine methylsulfate an apparent specific for arachnidism (black widow spider bite) | |
| CN112274644A (zh) | 一种用于治疗脊柱与骨关节病变并减轻其疼痛的药物 | |
| RU2816021C1 (ru) | Способ лечения сахарного диабета в комплексе с даларгином | |
| RU2416413C1 (ru) | Средство для лечения кровопотери ("спаскровь") | |
| JP2020045332A (ja) | 慢性便秘症を治療するための医薬組成物 | |
| RU2306149C2 (ru) | Способ лечения больных с затяжной пневмонией с применением препарата "рузам" |